Axon Enterprise, Inc. (NASDAQ:AXON) Shares Sold by New York Life Investment Management LLC

New York Life Investment Management LLC lowered its holdings in Axon Enterprise, Inc. (NASDAQ:AXON) by 0.5% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 10,054 shares of the biotechnology company’s stock after selling 48 shares during the period. New York Life Investment Management LLC’s holdings in Axon Enterprise were worth $2,597,000 as of its most recent SEC filing.

Several other large investors also recently made changes to their positions in AXON. Sands Capital Management LLC increased its position in shares of Axon Enterprise by 31.1% in the third quarter. Sands Capital Management LLC now owns 2,612,305 shares of the biotechnology company’s stock worth $519,823,000 after acquiring an additional 619,179 shares in the last quarter. Westfield Capital Management Co. LP grew its holdings in Axon Enterprise by 184.3% during the 3rd quarter. Westfield Capital Management Co. LP now owns 696,193 shares of the biotechnology company’s stock valued at $138,535,000 after purchasing an additional 451,350 shares in the last quarter. Polar Capital Holdings Plc grew its holdings in Axon Enterprise by 292.0% during the 3rd quarter. Polar Capital Holdings Plc now owns 265,464 shares of the biotechnology company’s stock valued at $52,825,000 after purchasing an additional 197,746 shares in the last quarter. Bank of New York Mellon Corp grew its holdings in Axon Enterprise by 28.3% during the 3rd quarter. Bank of New York Mellon Corp now owns 726,400 shares of the biotechnology company’s stock valued at $144,546,000 after purchasing an additional 160,359 shares in the last quarter. Finally, International Assets Investment Management LLC acquired a new stake in Axon Enterprise during the 4th quarter valued at $39,907,000. Institutional investors and hedge funds own 79.08% of the company’s stock.

Axon Enterprise Trading Up 0.6 %

Axon Enterprise stock opened at $318.55 on Monday. The firm’s 50-day moving average is $308.83 and its 200-day moving average is $265.60. The company has a debt-to-equity ratio of 0.42, a quick ratio of 2.66 and a current ratio of 3.00. Axon Enterprise, Inc. has a 1 year low of $175.37 and a 1 year high of $329.87. The company has a market cap of $24.04 billion, a P/E ratio of 138.50 and a beta of 0.91.

Axon Enterprise (NASDAQ:AXON) last released its quarterly earnings data on Tuesday, February 27th. The biotechnology company reported $0.77 earnings per share for the quarter, topping analysts’ consensus estimates of $0.48 by $0.29. Axon Enterprise had a net margin of 11.14% and a return on equity of 14.11%. The business had revenue of $432.14 million for the quarter, compared to analysts’ expectations of $418.97 million. On average, equities analysts expect that Axon Enterprise, Inc. will post 2.44 earnings per share for the current year.

Analyst Upgrades and Downgrades

A number of equities research analysts recently weighed in on the stock. JPMorgan Chase & Co. raised their price target on shares of Axon Enterprise from $330.00 to $365.00 and gave the company an “overweight” rating in a report on Thursday, April 11th. StockNews.com downgraded shares of Axon Enterprise from a “buy” rating to a “hold” rating in a research note on Thursday, March 14th. TheStreet downgraded shares of Axon Enterprise from a “b” rating to a “c+” rating in a research note on Tuesday, February 27th. Needham & Company LLC reiterated a “buy” rating and set a $400.00 price objective on shares of Axon Enterprise in a research note on Wednesday, April 24th. Finally, JMP Securities increased their price objective on shares of Axon Enterprise from $320.00 to $375.00 and gave the company a “market outperform” rating in a research note on Wednesday, May 1st. Two investment analysts have rated the stock with a hold rating and ten have given a buy rating to the stock. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $323.09.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.